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Elongation factor P is modiﬁed with (R)-b-lysine by the lysyl-tRNA synthetase (LysRS) paralog PoxA.
PoxA speciﬁcity is orthogonal to LysRS, despite their high similarity. To investigate a- and b-lysine
recognition by LysRS and PoxA, amino acid replacements were made in the LysRS active site guided
by the PoxA structure. A233S LysRS behaved as wild type with a-lysine, while the G469A and A233S/
G469A variants decreased stable a-lysyl-adenylate formation. A233S LysRS recognized b-lysine bet-
ter than wildtype, suggesting a role for this residue in discriminating a- and b-amino acids. Both
enantiomers of b-lysine were substrates for tRNA aminoacylation by LysRS, which, together with
the relaxed speciﬁcity of the A233S variant, suggest a possible means to develop systems for
in vivo co-translational insertion of b-amino acids.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The accurate translation of mRNA to protein requires the assis-
tance of adaptor molecules capable of binding to both the mRNA
codon and the cognate amino acid to be incorporated. These sub-
strates for protein synthesis are termed aminoacyl-tRNAs (aa-
tRNAs), and there exist tRNAs with the correct anticodon regions
to translate each amino acid of the genetic code. Cognate amino
acids are esteriﬁed onto the 30-end of the mature transfer RNA
(tRNA) through a reaction catalyzed by aminoacyl-tRNA syntheta-
ses (aaRSs). This aminoacylation reaction occurs in two steps: ﬁrst
the amino acid is activated with ATP to form an aminoacyl-adenyl-
ate (aaAMP), and second the activated amino acid is transferred to
its associated tRNA [1]. Each aa-tRNA is synthesized by a unique
aaRS enzyme, with cognate pairing of the tRNA and amino acid di-
rected by preferential binding of the cognate amino acid and selec-
tive editing of near-cognate amino acids [1].
Although their main function is to synthesize aa-tRNAs for pro-
tein synthesis, aaRSs have roles in addition to translation of the ge-
netic code. Recently it was discovered that binding of aa-tRNAs to
EF-Tu is not necessarily an irreversible commitment to proteinchemical Societies. Published by E
logy, The Ohio State Univer-
2, USA. Fax: +1 614 292 8120.
ciences, College of Medicine,
, Orlando, FL 32826, USA.synthesis [2], indicating that aa-tRNAs may deliver amino acids
to various other biological pathways. These alternative cellular
routes for activated amino acids include lipid modiﬁcation path-
ways, cyclodipeptide formation and antibiotic biosynthesis [3,4].
Furthermore, the aaRS super family contains several known aaRS
paralogs that mimic either the core or the appended domains of
canonical aaRSs [5]. AaRS paralogs generally retain some speciﬁcity
for their canonical substrates, amino acid or tRNA, regardless of
whether they function in translational pathways or have adapted
a function outside of protein synthesis. Known paralogs function
in trans to enhance aaRS activity, while others assist in tRNA and
aaRS passage between the cytoplasm and nucleus, amino acid or
antibiotic biosynthesis, or translation regulation [5–7]. PoxA is a
paralog of class II lysyl-tRNA synthetase (LysRS) and shares 32%
identity and 50% similarity to the C-terminal domain of this en-
zyme [8]. LysRS is responsible for catalyzing the transfer of L-a-ly-
sine to its cognate tRNA, but, despite their high homology, PoxA is
incapable of transferring a lysine residue onto tRNALys. Instead,
PoxA speciﬁcally catalyzes the addition of (R)-b-lysine onto lysine
34 of elongation factor-P in an ATP-dependent manner [9,10]. De-
spite the substantial similarity between their active sites, PoxA and
LysRS are highly speciﬁc for b- and a-amino acids, respectively
[10–12]. Structural comparisons suggest that two analogous non-
conserved residues, G465 and A229 of LysRS and A298 and S76
of PoxA, determine speciﬁcity for substrate recognition and
binding, as well as optimal enzymatic activity. To mimic thelsevier B.V. All rights reserved.
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A294G (Escherichia coli PoxA numbering) were created and tested
for enzymatic activity. While the S76A variant abolished activity,
the A294G mutant decreased the KM for L-a-lysine by 25-fold
[10]. Thus, PoxA adopted a method of substrate recognition distinct
from that of its paralog LysRS, indicating divergent evolution of the
two enzymes from ancestral aaRSs. Also the modest, yet signiﬁ-
cant, difference in substrate usage indicates molecular evolution
of a- vs. b-amino acid speciﬁcity. In this study we extended ac-
tive-site engineering to LysRS to further investigate the basis for
a- vs. b-amino acid discrimination in the aaRS super family.
2. Materials and methods
2.1. Strain, plasmids and general methods
Bacillus cereus lysS-encoded LysRS cloned into the pTYB1 vector
was excised and ligated into the pQE31 vector to produce the wild
type template for all subsequent experiments. Sets of two primers
containing 33 nucleotides each were used to create the LysRS
variants. The following primers were used to create the two single
mutants: A233S 50 TTATATATGCGTATCTCTATTGAGCTACATTTA
30 and 50 TTATATATGCGTATC TCTATTGAGCTACATTTA 30; G469A
50 CCTACGGGTGGATTAGCAATCGGTAT TGATCGT 30 and 50 CCTA
CGGGTGGATTAG CAATCGGTTATTGATCGT 30. Using Pfu Turbo DNA
polymerase, site-directed mutagenesis PCR reactions were per-
formed in accordance with manufacturer’s instructions (Strate-
gene). Following PCR, products were digested with DpnI and used
to transform XL1-Blue cells. Each point mutation was conﬁrmed
byDNA sequencing. A 100 mg/ml stock of L-a-lysinewasmade from
Acros Organics L(+)-Lysinemonohydrochloride (99+%). (R)-b-Lysine
was provided by the laboratory of Dr. Craig Forsyth, Department of
Chemistry, The Ohio State University [13]. (S)-b-Lysine was a gift
from Dr. Michael Thomas, Department of Bacteriology, University
ofWisconsin-Madison. In vivo assays of lysine-dependent gentami-
cin resistance were assessed as previously described [10].
2.2. Lysyl-tRNA synthetase puriﬁcation
B. cereus lysS-encoded LysRS variants cloned into the pQE31
vector were expressed in E. coli XL1-Blue cells. Transformants were
grown at 37 C in 1 l of LB broth supplemented with ampicillin
(100 lg/ml) to cell density OD600 = 0.6. Expression of lysS was in-
duced through the addition of 0.5 mM IPTG and cells were grown
for an additional 4.5 h. Cells were harvested at 4 C through centri-
fugation at 5000g for 5 min. Pelleted cells were washed with 0.1 M
Tris–HCl, pH 8 and stored at 80 C prior to puriﬁcation. Frozen
cell pellets were ﬁrst resuspended in 10 ml Buffer 1 [25 mM
Tris–HCl (pH 8), 300 mM NaCl, 10% (v/v) glycerol and 5 mM imid-
azole] supplemented with protease inhibitor cocktail (Roche Diag-
nostics). Cells were disrupted by passing through a French Pressure
cell (3 times at 1000 p.s.i.) and cell debris was pelleted by centrifu-
gation at 75000g for 45 min at 4 C. Supernatant was then loaded
onto a column composed of 3 ml of Talon metal afﬁnity resin (BD
Bioscience) at 4 C, pre-equilibrated with Buffer 1. The column
was then washed with 250 ml Buffer 1 at 4 C. Ten column frac-
tions of 1.5 ml were eluted with 25 mM Tris–HCl, pH 8, 300 mM
NaCl, 10% (v/v) glycerol and 250 mM imidazole at room tempera-
ture. Aliquots of each fraction were analyzed by SDS–PAGE and
fractions 1–4 were pooled and dialyzed overnight against 50 mM
Tris HCl, pH 8, 1 mM MgCl2, 10 mM b-mercaptoethanol, and 10%
(v/v) glycerol at 4 C. Proteins were further dialyzed for 4 h at
4 C against storage buffer [50 mM Tris–HCl (pH 8), 1 mM MgCl2,
10 mM b-mercaptoethanol, and 50% (v/v) glycerol] and stored at
20 C until use.2.3. Active-site titration
Active-site titration was performed in 100 mM Hepes (pH 7.2),
30 mM KCl, 10 mM MgCl2, 4 mM ATP, 50 lM [14C]-L-a-lysine,
and 1 unit of inorganic pyrophosphatase. Following preincubation
at 37 C for 1–2 min, the reaction was initiated through addition of
1 lM LysRS to the reaction mixture. After 10 min incubation at
37 C, samples were placed on ice to terminate the reaction. The
entire 50 ll reaction volume was then spotted onto nitrocellulose
ﬁlters presoaked in 50 mM Hepes (pH 7.2), 15 mM KCl, and
5 mM MgCl2. Filters were washed with 5 ml buffer containing
50 mM Hepes (pH 7.2), 15 mM KCl, and 5 mM MgCl2 and dried
for 25 min at 80 C. The amount of complex retained was quanti-
ﬁed through scintillation counting (Ultima Gold, Packard Instru-
ment Co.).
2.4. ATP-PPi exchange
The ATP-PPi exchange reaction was carried out in 100 mM
Hepes (pH 7.2), 30 mM KCl, 15 mM MgCl2, 10 mM NaF, 3 mM
ATP, 5 mM DTT, 3 mM [32P]PPi, 37 nM–4 lM LysRS, and a range
of lysine concentrations from 42.3 lM to 50 mM for L-a-lysine or
7 mM for (S)-b-lysine or (R)-b-lysine. The reaction mixture was
preincubated for 2 min and the reaction was initiated by the addi-
tion of amino acid. Aliquots of 10–15 ll were quenched by addition
of quenching solution (5.6% perchloric acid, 1% Norit A charcoal,
and 75 mM PPi) at different time points. ATP absorbed on charcoal
was ﬁltered over 3 MM Whatman GF/C ﬁlter disks, washed three
times with 5 ml of water and once with 5 ml 100% ethanol, and
dried at 80 C for 20 min. The amount of [32P]-ATP formed was
quantiﬁed through scintillation counting (Ultima Gold, Packard
Instrument Co.).
2.5. Aminoacylation
Aminoacylation was performed at 37 C in 100 mM Hepes
(pH 7.2), 30 mM KCl, 10 mMMgCl2, 2 mM ATP, 50 lM [14C]-L-a-ly-
sine, 10 mg/ml E. coli total tRNA, and 500 nM LysRS. At 2, 4, 8, and
12 min, 9 ll aliquots were quenched on 3 MMWhatman GF/C ﬁlter
disks presoaked in 5% TCA (w/v). Following the ﬁnal timepoint, ﬁl-
ter disks were washed 3 times for 5 min at room temperature in 5%
(v/v) TCA solution, and rinsed in 100% ethanol prior to baking at
80 C for 20 min. The level of [14C]-lysyl-tRNALys was then quanti-
ﬁed through scintillation counting (Ultima Gold, Packard Instru-
ment Co.). Aminoacylation with non-radioactive amino acids was
also monitored as previously described using E. coli 32P-A76
tRNALys [11,14].
3. Results
3.1. Selection and characterization of LysRS variants
B. cereus LysRS was used here due to the high degree of homol-
ogy of its active site to that of Geobacillus stearothermophilus LysRS,
whose structure and function has been extensively characterized,
and its strong similarity to the active site of PoxA. B. cereus and
G. stearothermophilus LysRS have 77.9% sequence identify and the
two organisms not only share the two divergent active site resi-
dues (G469 and A233, B. cereus numbering) but also retain the
11 conserved residues found to be critical for Salmonella PoxA
activity in vivo [8]. To investigate the role of the residues that have
diverged between the LysRS and PoxA active sites, the B. cereus
LysRS variants A233S, G469A and A233S/G469A were constructed
and characterized (Fig. 1). Aminoacylation reactions were per-
formed with wild type and mutant proteins to qualitatively evalu-
Fig. 1. Amino acid binding by LysRS. The 20 amino acids forming the lysyl-
adenylate binding pockets of PoxA and LysRS are identical, apart from the two
positions indicated in red [8]. For clarity, only 14 residues are represented. Crystal
structure is LysRS from Bacillus stearothermophilus [25]. The Van der Waals surface
of the lysyl-adenylate is represented and the replacements studied here are
indicated with B. cereus residue numbering.
Table 1
Steady-state kinetics of L-a-lysine activation by B. cereus LysRS wild type and variants.
KM (lM) kcat (min1) kcat/KM (min1/lM)
Wild type 160 ± 70 2500 ± 30 16
A233S 210 ± 60 5100 ± 490 24
G469A 3900 ± 1200 490 ± 30a 0.13
A233S/G469A NDb
Errors correspond to the standard deviation of three independent experiments.
a Based on estimated active yield, see text for details.
b Kinetic parameters for the LysRS variant A233S/G469A could not be
determined.
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replacement, which showed that all proteins retained varying de-
grees of activity (Fig. 2). For quantitative kinetic analyses, enzyme
concentrations were determined by active site titration, revealing
active yields of 38% and 22% for wild type and A233S LysRS, respec-
tively. However, G469A and A233S/G469A proteins did not show
activity in active-site titration assays presumably due to unstable
binding of [14C]-lysyl-adenylates, and their concentrations were
instead predicted based on total protein assays and an estimated
active fraction of 30% (the average of the active fractions observed
for wild type and A233S LysRS). The effect of each replacement on
the steady-state kinetics of tRNA-independent cognate amino acid
recognition was then investigated using the ATP/PPi exchange
reaction, with L-a-lysine as substrate (Table 1). Kinetic parameters
could not be accurately determined for A233S/G469A LysRS by
ATP/PPi exchange, perhaps as a result of reduced lysyl-adenylateFig. 2. Aminoacylation of LysRS wild type and variants. Reactions were performed
with 50 lM a-lysine and 10 mg/ml E. coli total tRNA in the presence of 0.5 lM
LysRS. Error bars represent the S.D. of three independent experiments.afﬁnity and/or stability. The A233S variant displayed little change
in the KM for L-a-lysine and a 2-fold increase in kcat, while the kcat
value for G469A decreased 17-fold and the KM for L-a-lysine in-
creased 24-fold compared to wild type (Table 1). Overall, ATP/PPi
exchange with a-lysine indicates that the G469A and A233S/
G469A replacements interfere with a-lysine binding and catalysis,
while the A233S replacement is not detrimental to normal LysRS
catalytic activity.
3.2. Non-cognate amino acid recognition by LysRS
Previous structural and functional studies of PoxA suggest that
replacement of Ala233 and or Gly469 in LysRS may potentially al-
ter b-lysine recognition. To explore the effects of active-site
replacements on the ability of LysRS to activate non-cognate forms
of lysine, ATP/PPi exchange reactions were performed with (S)-b-
lysine and (R)-b-lysine. While (R)-b-lysine is the physiological sub-
strate of PoxA, the ability of LysRS to activate (S)-b-lysine was also
tested, as it was possible that active site replacements might alter
the speciﬁcity but not the enantiomeric selectivity of substrate rec-
ognition by LysRS. Due to low activity with both forms of b-lysine,
it was not possible to determine steady-state kinetic parameters;
however, activity was detected for wild type and the A233S vari-
ant, with both proteins stimulating ATP/PPi exchange activity to
a greater extent with (S)-b-lysine than with (R)-b-lysine (Fig. 3).
Neither the G469A nor the A233S/G469A variants showed stimula-
tion of the ATP/PPi exchange reaction with b-lysine. Although
activity with (R)-b-lysine was comparable for wild type and the
A233S mutant, stimulation of lysyl-adenylate formation with (S)-
b-lysine was signiﬁcantly greater for the latter, indicating that
the A233S replacement alters the substrate speciﬁcity of the LysRS
active site to better accommodate b-lysine. The A233S replace-
ments did not alter the enantiomeric selectivity of LysRS with re-
spect to b-lysine, suggesting that changes to some other aspects
of the respective active sites are responsible for this property of
PoxA.
To investigate if activated b-lysine could be subsequently trans-
ferred to tRNA, aminoacylation reactions were performed with
[32P]-A76 tRNALys, and products analyzed by nuclease digestion
and resolution of aa-[32P]-A76 by thin layer chromatography. Only
a-lysine was a substrate for aminoacylation at catalytic LysRS lev-
els (Fig. 4a); at elevated enzyme concentrations wild type and the
A233S variant showed higher levels of aminoacylation with (S)-,
and to a lesser extent (R)-, b-lysine than G469A or A233S/G469A
LysRS (Fig. 4b).
3.3. Cellular uptake and metabolism of b-lysine
The above ﬁndings show that LysRS can be manipulated to im-
prove (S)-b-lysine recognition, suggesting that this may be a useful
route for the future development of in vivo systems to generate
peptides containing b-amino acids. In addition to a suitably modi-
ﬁed LysRS activity, such systems must also be able to take up the
Fig. 3. Amino acid speciﬁcity of LysRS wild type and variants. ATP-[32P]-PPi exchange catalyzed by wild type (j) and A233S LysRS (h) with (S)-b-lysine (A) and (R)-b-lysine
(B). Formation of [32P]-ATP was monitored in the presence of 7 mM b-lysine and 4 lM LysRS. Error bars represent the S.D. of three independent experiments. Neither G469A
nor A233S/G469A LysRS stimulated detectable ATP/PPi exchange under these conditions.
Fig. 4. TLC analysis of tRNALys aminoacylation by a- and b-lysine. Aminoacylation was performed as described, using 0.1 lM (A) or 4 lM (B) LysRS, 0.5 lM [32P]-tRNALys and
10 mM lysine as indicated (a, L-a-lysine; R, (R)-b-lysine; S, (S)-b-lysine). S1 nuclease was added as shown.
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investigated using an in vivo assay based upon the post-transla-
tional modiﬁcation of EF-P with b-lysine [10]. Gentamicin resis-
tance in Salmonella is modulated by the post-translational
modiﬁcation of EF-P with (R)-b-lysine, and deletion of the gene
encoding the lysine aminomutase responsible for (R)-b-lysine syn-
thesis (yjeK) decreases growth in the presence of the antibiotic.
Growth of the yjeK mutant strain in the presence of gentamicin
can be restored by the addition of exogenous (R)-b-lysine, which
is taken up by cells and then used to modify EF-P. Both (S)-b-lysine
and (R)-b-lysine were able to restore growth of the yjeK mutant
strain, indicating that both amino acids were readily taken up by
the cells (Fig. 5). While the uptake and use of (R)-b-lysine had pre-
viously been demonstrated [10], functional rescue of the yjeK mu-
tant by (S)-b-lysine was unexpected. (S)-b-lysine is not a substrate
for EF-P modiﬁcation in vitro, and the data shown here now sug-
gest that after cellular uptake it is at least partially converted to
the (R)-form by an as yet undeﬁned process.4. Discussion
The active sites of bacterial LysRS superfamily members are
highly conserved. For example, structures of representative PoxA
and LysRS lysine binding pockets differ by an R.M.S.D. of 1.1 Å
and are identical at 12 of the 14 residues within the respective sites
(Fig. 1). The two residues that vary across the bacterial LysRS
superfamily are themselves conserved within their respective sub-
class, to which they impart speciﬁc attributes. Previous studies
showed that replacement of one of these residues in PoxA,
Ala294, with glycine to mimic the conserved LysRS active-site res-
idue abolished PoxA’s speciﬁcity for L-a-lysine [10]. Changing the
corresponding residue in B. cereus LysRS, Gly469, severely impaired
activity and decreased afﬁnity conﬁrming the role of this position
in amino acid binding. Nevertheless, mutating this position did
not allow PoxA to use a-lysine or LysRS to use b-lysine as their pre-
ferred substrate indicating that other residues also determine
speciﬁcity. One such residue is Ala233, which was changed to Ser
Fig. 5. Complementation of Salmonella yjeK deletion strain with (R)- and (S)-b-lysine. Growth in liquid LB + 8 lg/ml gentamicin for 24 h at 37 C. Growth was monitored in
the absence (–) or presence of 0.8 mM (R)-b-lysine, (S)-b-lysine, or L-a-lysine. Optical densities of replicate cultures are plotted and error bars represent standard deviations.
Growth rates were consistently slower in (R)-b-lysine, suggesting a modest inhibitory effect at the concentrations used, the reason for which is presently unclear.
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improvement in b-lysine speciﬁcity without any loss in canonical
L-a-lysine tRNA aminoacylation activity. Overall the changes in
LysRS speciﬁcity achieved by changing Ala233 and Gly469 to their
PoxA equivalents were relatively modest, suggesting that addi-
tional residues precisely position functional groups involved in
substrate recognition and binding. A similar situation has been de-
scribed for the TyrRS active site, where single residue changes have
fairly modest effects but more extensive changes at multiple posi-
tions have dramatic effects on substrate speciﬁcity [15–17].
When considered in the context of recent success in the re-engi-
neering of various aaRS substrate activities [18,19], it is reasonable
to expect that further active-site engineering efforts could substan-
tially increase the speciﬁcity of LysRS for b-Lys-tRNA synthesis. The
emerging signiﬁcance of b-amino acids in drug discovery focuses
interest on engineering aaRSs such as LysRS for use with unnatural
amino acids [12]. b-Amino acids are extremely structurally diverse,
and, as they are not encoded in natural proteins but are excellent
mimics, they are of interest as peptidomimetics and indrugdiscovery
research [20–22]. b-aa-tRNAs are not efﬁcient substrates for the elon-
gation phase of protein synthesis [23], but recent studies have shown
they can be incorporated via the initiationmachinery indicating their
potential use in protein design and engineering [24]. Our ﬁndings
that LysRS has the potential to be modiﬁed to utilize b-lysine efﬁ-
ciently, and that cells can readily take up such amino acids, nowsug-
gest possible strategies to develop systems that would allow site-
directed b-amino incorporation into proteins in vivo.
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